Enhanced recovery for colorectal surgery during COVID-19

Enhanced recovery for colorectal surgery during COVID-19

William John Fawcett1^, Timothy Alexander Rockall2,3

1Department of Anaesthesia, Royal Surrey County Hospital NHS Foundation Trust, Guildford, UK; 2Department of Surgery, Royal Surrey County Hospital NHS Foundation Trust, Guildford, UK; 3The Minimal Access Therapy Training Unit, University of Surrey, Guildford, UK

^ORCID: 0000-0003-0696-1112.

Correspondence to: William John Fawcett. Department of Anaesthesia Royal Surrey County Hospital NHS Foundation Trust, Guildford, UK. Email: wjfawcett@gmail.com.

Received: 03 July 2020; Accepted: 21 October 2020; Published: 20 January 2021.

doi: 10.21037/ales-20-98

Over the last decade, the improved delivery of high quality colorectal surgery has been possible due to advances in surgery and perioperative medicine, typified by the application of multidisciplinary, evidenced based care within initiatives such as enhanced recovery after surgery (ERAS) programmes. In this editorial we will suggest an increased relevance of ERAS and how its benefits may be extended to mitigate some of the serious problems in the current health crisis caused the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2 or COVID-19) COVID-19 pandemic.

COVID-19 has produced unheralded challenges for the delivery of healthcare. During its peak, clinical activity was directed to the management of patients acutely unwell with COVID-19, with all but the most urgent surgery suspended. Following this surge, the need to restart less urgent surgery, particularly major cancer surgery, and to tackle the backlog and ongoing need has been addressed by many UK professional bodies including surgeons and anaesthetists (1,2). Broadly similar themes run through the information supplied by two websites, including reconfiguration to provide adequate space, staff, and equipment with appropriate systems in place to ensure the safety of both patients and staff and all underpinned by strong leadership and delivering appropriate training. Of all these, a major issue revolves around patient safety during the pandemic, with the recognition that postoperative pulmonary complications (PPCs) occur in just over half of patients (51%) with perioperative COVID-19 infection, with an associated mortality of 38% in these patients, accounting for nearly 83% of deaths (3). Thus balancing the risks of when and what type surgery to undertake in those at risk can be a nuanced decision.

Prior to the pandemic, the numbers of patients undergoing colorectal surgery within ERAS programmes was increasing worldwide. The initial raison d'être of ERAS was to reduce hospital length of stay (LOS) popularised by Kehlet in both open and laparoscopic surgery colorectal over 25 years ago (4,5). Further work by Kehlet started a revolution in multimodal perioperative care. It was soon evident however that the benefits of ERAS extended far beyond a reduced LOS (6) and growing evidence has demonstrated that ERAS programmes have a profound impact, including a reduction in complications, long term cancer recurrence, cost of treatment and time to return to normal function (7), with much of the demonstrated benefits collected from colorectal surgery (8,9). Most recently a large meta-analysis confirmed the positive impact that ERAS pathways conferred on reducing PPCs, significantly reducing that risk more than any other of the interventions. The number of patients needed to treat (95% CI) on ERAS pathways was 8 (4.9–12.9) to provide this benefit (10).

Patients currently presenting for colorectal surgery require, now more than ever, excellence in multimodal perioperative care. The importance of guidelines adherence is crucial as there is good evidence that improved adherence confers greater benefits, including reduced complications (11) and improved cancer survival (12). The most recent ERAS® Society recommendations list 25 guideline elements (13) and whilst many of these may be applied in the usual manner, some require modification during the current pandemic.


The preoperative period is the key time to optimise patients and delay in surgery has changed the landscape for patients. On the one hand, disease progression may have occurred, increasing the magnitude of the proposed surgery, yet it allows further time to undertake optimisation. The marked reduction of face-to-face consultations was unfamiliar territory to many frontline clinicians, but the pandemic has revolutionised this area, and the use of telemedicine has been described in many aspects of patient care including preoperative assessment (14). A number of barriers have to be faced including broadband quality, a secure platform, training for both staff and patients, and finally assistance for those with cognitive and hearing impairments.

Patient blood management has been revolutionised in the last 5 years. Patients presenting for surgery with anaemia are well recognised to require increased transfusions, increased LOS, more frequent intensive care admissions, infections, thromboembolic events, and mortality (15). The increase use of preoperative intravenous iron infusions is less practical during the pandemic, and oral preparations will have to be used more often. Whilst these are limited by gastrointestinal side effects, alternate day treatments and the use of newer agents (e.g., sucrosomial iron) may improve compliance (16).

A poor level of aerobic fitness and functional capacity is well recognised to play a key role in determining patient outcome for major surgery (17). Whilst this may be assessed subjectively (such as by a questionnaire), objective assessments for the patient categorised at higher risk via cardiopulmonary exercise testing has recently been re-evaluated. In addition to the issues concerning its reintroduction (i.e., staff safety during testing) there is little data on how to interpret results on patients who have suffered significant COVID-related lung injury (18). However, it is fundamental to make an assessment of fitness and functional capacity for all patients undergoing surgery, as those at high risk may need further input such as referral to high risk anaesthetic clinic or further input form the multidisciplinary team, so that appropriate shared decision making can be undertaken, with the patient triaged for their postoperative care. Whilst the evidence for prehabilitation is still emerging, preoperative exercise training (e.g., high intensity exercise training) may convey improvements in outcome, particularly for patients undergoing cancer surgery (17,19), and may even cause regression of colorectal tumour size prior to surgery (20). Whilst it is easier with lockdown restrictions reduced, the use of fitbitTM technology can theoretically permit a tailored approach to prehabilitation (21), although it is not known how feasible it is to deliver this training remotely. However, it is feasible to run online exercise classes for patients to improve their preoperative fitness and these resources should be harnessed. In addition, it must not be forgotten that prehabilitation also wider remits such as dietary improvements and also psychological support, and there is current interest in the latter (22) which is also feasible to supply remotely, such as with support classes or one to one interactions. Finally help can be targeted to reduce alcohol and nicotine intake too, although the effectiveness of virtual intervention is unknown.


The reliable availability of anaesthetic drugs was feared an initial concern at the onset of the pandemic, leading to a return to older style volatile anaesthetics, such as isoflurane. Generally, this has not been the case, although there have been local shortages of drugs for total intravenous anaesthesia (TIVA), due to their prioritised use for critical care patients. This has rekindled the debate as to the optimum general anaesthetic—volatile or TIVA—for patients undergoing oncological surgery. Whilst there is a wealth of theoretical evidence and an interest in increasing long-term survival after some cancer surgeries (such as breast and oesophageal cancer), there is not enough evidence to recommend a wholesale switch to TIVA from volatile anaesthesia (23,24). Meticulous adherence to the intraoperative protocolised pathways such as avoidance of hypothermia, correct fluid therapy, multimodal opioid sparing analgesia and avoidance of hyperglycaemia are also required (13). Confirming adequate reversal form neuromuscular blockade is essential to minimise the incidence of PPCs and Sugammadex has an emerging role in this area (25), as well as within its place to reverse deep neuromuscular blockade (DNB—see below)

The relative merits of laparoscopic surgery compared to open surgery caused controversy during the pandemic, as both have the potential to release and disseminate viral particles, either from uncontrolled release of pressurized gas (in laparoscopic surgery) or the use of electrocautery (in open surgery) and advice has recently been published on how to reduce risk of both techniques (26). However, there is no doubt in terms of overall patient outcome, that skilled laparoscopic surgery offers the best way forward and recent advice suggests that laparoscopic surgery provides a safe option with the creation of a closed circuit and providing ultra low particulate air (ULPA) filters, necessary to entrap the virus (0.06–0.14 µm). Moreover, the risk can be reduced further by using low flow rates (5–10 L/min of CO2) and lower intraperitoneal pressures (8–10 mmHg), the latter enabled by the use of DNB (27). Whilst the place of DNB is not yet confirmed, early studies suggest lower pain scores, earlier return of gastrointestinal function overall improved surgical space and with no difference in operative times (27), with preservation of cardiac output (28). The most recent data suggests that an individualised rather than a standardised approach to pneumoperitoneum may ultimately prove to be the most useful, with reduced complications and reduced inflammation (29).

At the start of the pandemic there were opinions and indeed guidance recommending open surgery rather than laparoscopic surgery with some even considering stoma formation rather than primary anastomosis to reduce the risk of complications that might necessitate the use of intensive care in the post-operative period (30). The evidence in favour of this strategy was mostly theoretical and really failed to recognise the huge adverse impact on the patients recovery and well-being. It is difficult to strike a balance between the theoretical increased risk to staff from aerosolised virus particles during laparoscopic surgery on the one hand and the considerable disadvantage to patient recovery on the other. The balance of risk between well conducted laparoscopic surgery and open surgery with potentially increased blood contact and diathermy smoke is uncertain however action to mitigate the risk by isolating and screening patients, using appropriate PPE and using well recognised strategies to reduce the aerosol risk has led to most clinicians continuing with the laparoscopic approach where appropriate (31).


Recently, there has been focus on the postoperative period for colorectal patients within ERAS programmes, where it is advocated that this time has the greatest potential impact and was independently associated with optimal recovery, defined as discharge within 5 days of surgery, no major complications nor readmissions to hospital nor mortality (32). This paper by Aarts et al. encouraged the early removal or avoidance of urinary catheters, assistance with patient mobilization and early feeding (water on day of surgery and solids on day one). Whilst these are recognized as often the most difficult areas to implement, they were nevertheless the area that conveyed most success to their patients. In an accompanying editorial to the Aarts’ paper, Kehlet focuses our attention not so much on the multitude of ERAS elements, but instead on the few he outlined three decades ago: preoperative patient information, thoracic epidural anaesthesia in open (but not laparoscopic) colonic surgery, avoidance of both fluid overload and hypovolemia, no nasogastric tube, and early oral feeding and mobilization. These steps were enough to deliver high quality ERAS with a low LOS (2 to 4 days after open colonic surgery) (33) and with patient selection and fastidious adherence to these few principals in high quality laparoscopic surgery can deliver even lower LOS (8,34).

The highest risk environment for COVID-19 is the hospital, so even when operating at clean or COVID-light sites any safe reduction in length of hospital stay will reduce the chances of contact and infection. The judicious early discharge supported by telephone contact and support of the patient and carers can help reduce this risk.

Other areas

Some surgeries are taking place after a considerable delay and as a result, there may be significant disease progression since the decision to operate. In addition, the infrastructure for working in unfamiliar environments (such as cancer hubs) requires meticulous administrative input to ensure patients’ notes, imaging and other test results are readily available. Finally, the necessity for feedback and audit results are essential to implement changes and improvements and to sustain high-level care (13).


Aarts’ paper reminds is that optimal recovery is significantly associated with laparoscopic surgery and overall compliance with ERAS recommendations. Other areas independently associated with optimal recovery are colon instead of rectal surgery and surgery for cancer compared with inflammatory bowel disease or diverticular disease. Delayed recovery was associated with preoperative anaemia, older age, ASA status of greater than 2 and creation of a stoma (32).

In the next few months, colorectal services are working against two opposing constraints: reduced theatre capacity and bed availability versus the requirement to save costs. This scenario is ideal for ERAS to flourish at a time when its benefits have never been more valuable to patients, healthcare professionals and society. Further benefits for patients will then rely on the impact of sound political and organisational improvements, such as a low COVID-19 prevalence in the community with effective testing and sufficient trained staff and resources, including PPE and ICU beds (3).


Funding: None.


Provenance and Peer Review: This article was a “unsolicited submission” to the journal. The article has undergone external peer review.

Peer Review File: Available at http://dx.doi.org/10.21037/ales-20-98

Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/ales-20-98). The authors have no conflicts of interest to declare.

Ethical Statement: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.


  1. Available online: (accessed 1 July 2020).https://www.rcseng.ac.uk/coronavirus/recovery-of-surgical-services/
  2. Available online: (accessed 1 July 2020).https://icmanaesthesiacovid-19.org/restarting-planned-surgery-in-the-context-of-the-covid-19-pandemic
  3. COVIDSurg Collaborative. Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study. Lancet 2020;396:27-38. [Crossref] [PubMed]
  4. Bardram L, Funch-Jensen P, Jensen P., et al. Recovery after laparoscopic colonic surgery with epidural analgesia, and early oral nutrition and mobilisation. Lancet. 1995;345:763-4. [Crossref] [PubMed]
  5. Kehlet H, Mogensen T. Hospital stay of 2 days after open sigmoidectomy with a multimodal rehabilitation programme. Br J Surg 1999;86:227-30. [Crossref] [PubMed]
  6. Fawcett WJ, Mythen MG, Scott MJP. Enhanced Recovery - more than just reducing length of stay? Br J Anaesth 2012;109:671-4. [Crossref] [PubMed]
  7. Ljungqvist O, Scott M, Fearon KC. Enhanced recovery after surgery: a review. JAMA Surg 2017;152:292-8. [Crossref] [PubMed]
  8. Levy BF, Scott MJ, Fawcett WJ, et al. 23-hour stay laparoscopic colectomy. Dis Colon Rectum 2009;52:1239-43. [Crossref] [PubMed]
  9. Levy BF, Scott MJ, Fawcett WJ, et al. Randomized clinical trial of epidural, spinal or patient controlled analgesia for patients undergoing laparoscopic colorectal surgery. Br J Surg 2011;98:1068-78. [Crossref] [PubMed]
  10. Odor PM, Bampoe S, Gilhooly D, et al. Perioperative interventions for prevention of postoperative pulmonary complications: systematic review and meta-analysis. BMJ 2020;368:m540. [Crossref] [PubMed]
  11. Ripollés-Melchor J, Ramírez-Rodríguez JM, Casans-Francés R, et al. POWER Study Investigators Group for the Spanish Perioperative Audit and Research Network (REDGERM). JAMA Surg 2019;154:725-36. [Crossref] [PubMed]
  12. Gustafsson UO, Hausel J, Thorell A, et al. Adherence to the enhanced recovery after surgery protocol and outcomes after colorectal cancer surgery. Arch Surg 2011;146:571-7. [Crossref] [PubMed]
  13. Gustafsson UO, Scott MJ, Hubner M, et al. Guidelines for Perioperative Care in Elective Colorectal Surgery: Enhanced Recovery After Surgery (ERAS®) Society Recommendations: 2018. World J Surg 2019;43:659-95. [Crossref] [PubMed]
  14. Mihalj M, Carrel T, Gregoric ID, et al. Telemedicine for preoperative assessment during a COVID-19 pandemic: recommendations for clinical care. Best Pract Res Clin Anaesthesiol 2020;34:345-51. [Crossref] [PubMed]
  15. Spahn DR, Muñoz M, Klein AA, et al. Patient Blood Management: Effectiveness and Future Potential. Anesthesiology 2020;133:212-22. [Crossref] [PubMed]
  16. Baron DM, Franchini M, Goobie SM, et al. Patient blood management during the COVID-19 pandemic-a narrative review. Anaesthesia 2020;75:1105-13. [Crossref] [PubMed]
  17. Tew GA, Ayyash R, Durrand J, et al. Clinical guideline and recommendations on pre-operative exercise training in patients awaiting major non-cardiac surgery. Anaesthesia 2018;73:750-68. [Crossref] [PubMed]
  18. Faghy MA, Sylvester KP, Cooper BG, et al. Cardiopulmonary exercise testing in the COVID-19 endemic phase. Br J Anaesth 2020;125:447-9. [Crossref] [PubMed]
  19. Richardson K, Levett DZH, Jack S, et al. Fit for surgery? Perspectives on preoperative exercise testing and training Br J Anaesth 2017;119:i34-i43. [Crossref] [PubMed]
  20. West MA, Astin R, Moyses HE, et al. Exercise prehabilitation may lead to augmented tumor regression following neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Acta Oncologica 2019;58:588-95. [Crossref] [PubMed]
  21. Allen S, Brown V, Prabhu P, et al. A randomised controlled trial to assess whether prehabilitation improves fitness in patients undergoing neoadjuvant treatment prior to oesophagogastric cancer surgery: study protocol. BMJ Open 2018;8:e023190. [Crossref] [PubMed]
  22. Levett DZ, Grimmett C. Psychological factors, prehabilitation and surgical outcomes: evidence and future directions. Anaesthesia 2019;74:36-42. [Crossref] [PubMed]
  23. Yap A, Lopez-Olivo MA, Dubowitz J, et al. Global Onco-Anesthesia Research Collaboration Group. Anesthetic technique and cancer outcomes: a meta-analysis of total intravenous versus volatile anesthesia. Can J Anaesth 2019;66:546-61. [Crossref] [PubMed]
  24. Wall T, Sherwin A, Ma D, et al. Influence of perioperative anaesthetic and analgesic interventions on oncological outcomes: a narrative review. Br J Anaesth 2019;123:135-50. [Crossref] [PubMed]
  25. Kheterpal S, Vaughn MT, Dubovoy TZ, et al. Sugammadex versus Neostigmine for Reversal of Neuromuscular Blockade and Postoperative Pulmonary Complications (STRONGER) A Multicenter Matched Cohort Analysis. Anesthesiology 2020;132:1371-81. [Crossref] [PubMed]
  26. Zheng MH, Boni L, Fingerhut A. Minimally invasive surgery and the novel coronavirus outbreak: lessons learned in China and Italy. Ann Surg 2020;272:e5-e6. [Crossref] [PubMed]
  27. Chadi SA, Guidolin K, Caycedo-Marulanda A, et al. Current evidence for minimally invasive surgery during the COVID-19 pandemic and risk mitigation strategies: a narrative review. Ann Surg 2020;272:e118-e124. [Crossref] [PubMed]
  28. Scott M, Blightman K, Dickinson M, et al. Improved oxygen delivery when operating at low intra-abdominal pressure using deep neuromuscular block during laparoscopic surgery. Anesth Analg 2017;124:139-40.
  29. Díaz-Cambronero O, Mazzinari G, Lorente BF, et al. Effect of an individualized versus standard pneumoperitoneum pressure strategy on postoperative recovery: a randomized clinical trial in laparoscopic colorectal surgery. Br J Surg 2020;107:1605-14. [Crossref] [PubMed]
  30. Di Marzo F, Sartelli M, Cennamo R, et al. Recommendations for general surgery activities in a pandemic scenario (SARS-CoV-2). Br J Surg 2020;107:1104-6. [Crossref] [PubMed]
  31. Francis N, Dort J, Cho E, et al. SAGES and EAES recommendations for minimally invasive surgery during COVID-19 pandemic. Surg Endosc 2020;34:2327-31. [Crossref] [PubMed]
  32. Aarts MA, Rotstein OD, Pearsall EA, et al. Postoperative ERAS interventions have the greatest impact on optimal recovery: experience with implementation of ERAS across multiple hospitals. Ann Surg 2018;267:992-7. [Crossref] [PubMed]
  33. Kehlet H. ERAS implementation—time to move forward. Ann Surg 2018;267:998-9. [Crossref] [PubMed]
  34. Gignoux B, Gosgnach M, Lanz T, et al. Short-term outcomes of ambulatory colectomy for 157 consecutive patients. Ann Surg 2019;270:317-21. [Crossref] [PubMed]
doi: 10.21037/ales-20-98
Cite this article as: Fawcett WJ, Rockall TA. Enhanced recovery for colorectal surgery during COVID-19. Ann Laparosc Endosc Surg 2021;6:2.